Page last updated: 2024-10-31

metyrapone and Anorectal Diseases

metyrapone has been researched along with Anorectal Diseases in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farmer, RG1
Schumacher, OP1

Other Studies

1 other study available for metyrapone and Anorectal Diseases

ArticleYear
Treatment of ulcerative colitis with hydrocortisone enemas. Comparison of absorption and clinical response with hydrocortisone alcohol and hydrocortisone acetate.
    The American journal of gastroenterology, 1970, Volume: 54, Issue:3

    Topics: 17-Hydroxycorticosteroids; Administration, Topical; Adolescent; Adrenal Cortex Hormones; Adult; Aged

1970